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Abstract-A longitudinal panel study examined the effects of actual use of diazepam (Valium” ) on 
subjective reports of life quality, affect. performance, stress, social support, control. coping and other 
variables related to mental health. Standardized interviews were conducted with 675 persons from the 
Detroit Metropolitan Area. Based on prescription records, diazepam users and nonusers were selected to 
represent a variety of sociodemopraphic characteristics rather than lo be a completely random sample. 
Significant pthers in work and in personal life were also interviewed. Four interviews took place. one 
approximately every 6 weeks. Testing for social effects was conducted by within- and across-person 
analyses of 367 respondents who reported taking the medication at some time during the study and by 
comparisons with 308 respondents who did not report taking Valium. Users of Valium tended 10 take 
less Valium than prescribed. They also reported consuming less alcohol when using Valium than at other 
times and less than non-Valium users. Although there was a modest. positive cross-sectional relation 
between Valium use and distress. numerous multivariate analyses controlling for levels of stress and health 
indicated no notable effects of Valium use on any of the social or psychological indicators. including 
anxiety. Several interpretations of the results are examined including the possibility that the effects of 
Valium use were short-lived rather than long-term and that Valium may have been taken in anticipation 
of anxiety rather than after its occurrence. 
INTRODUCTlON 
A large body of clinical trial literature has demon- 
strated the anxiolytic properties of benzodiazepines 
(for an extensive review. see Greenblatt and Shader 
[I]). At the same time, there has been controversy 
regarding the social and psychological effects of 
minor tranquilizers as used in society [2-41. Despite 
this controversy, there has been little systematic 
research on the social effects of r~pical use. This study 
addresses this controversy by examining typical use, 
rather than use in a clinical trial, and by focusing on 
long-term effects with a longitudinal panel design. 
The study examines the consequences of tranquil- 
izer use in people who were nbt participating in 
clinical trials. As necessary substitutes for the ran- 
domization and pre-experiment washout periods of 
formal clinical trials. the study uses multivariate 
statistical modeling techniques to capitalize on natu- 
ral variation in tranquilizer use. 
Previous large-scale survey research on psycho- 
social correlates of anxiolytic use has been cross- 
sectional [5.6]. Such studies were not designed to 
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distinguish among the antecedents, noncasual cor- 
relates and consequences of using minor tranquil- 
izers. This study used a longitudinal survey design to 
search for consequent, relatively-enduring social 
effects such as changes in the ability to cope, in sense 
of control, and in the well-being of significant others 
such as a spouse. The study attempted to address 
social concerns about relatively permanent rather 
than transitory social effects of tranquilizer use [24], 
and so the design precluded detection of short-term 
effects such as relatively immediate (e.g. within hours) 
effects on affect, well-being or performance. 
Focus on Valium 
In order to examine the correlates of variation in 
the pattern of tranquilizer use efficiently, a single 
brand of medication was studied. Diazepam 
(Valium ” ) served this purpose best because it was the 
most commonly prescribed tranquilizer in the United 
States [7], and is frequently mentioned as an example 
of a minor tranquilizer in the literature. Throughout 
the text, the proprietary name ‘Valium’ will be used 
because this is the way respondents referred to di- 
azepam. No endorsement whatsoever is intended by 
this usage. 
Theoretical jiiamework 
Several basic hypotheses guided the study. One was 
that environmental stress, or demands and threats in 
personal and in work life, and the demands and 
threats of illness increase emotional strain such as 
anxiety [8]. Stress was also predicted to reduce life 
quality and performance. These hypotheses have 
been supported by numerous studies on how life 
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events as well as day-to-day events and conditions 
influence emotional well-being and behavior (e.g. 
19, 111). 
It was further hypothesized that coping by chang- 
ing how one viewed the problem, by expressing or 
controlling one’s emotions, and by dealing directly 
with the cause of the problem could reduce stress. 
strain or the relation between them depending on the 
target of the coping. If Valium use alters the ability 
to cope. it could. in addition to having direct anx- 
iolytic effects, indirectly influence all the above- 
mentioned effects of coping. 
The study also examined whether the use of Va- 
lium influences the well-being of persons around the 
user. For example, the well-being of a spouse or a 
co-worker, and their ability to provide social support 
[l6], might be influenced by the emotional state of the 
user and by any effects that Valium use might have 
on the ability of the user to cope with daily problems. 
This framework suggested a variety of outome 
variables, referred to as potential social effects. These 
included sense of control, provision as well as elic- 
itation of social support. affective states (anxiety, 
depression, anger), perceived quality of life (satis- 
faction), the use of alcohol, caffeine, and other drugs 
and ability to manage one’s emotions and to perform 
responsible roles in work and personal life*. The 
well-being of significant others, noted above, also 
constituted an outcome variable. The study was not 
designed to examine drug dependence (e.g. [14]) or 
drug abuse. 
Hypotheses were generated which considered di- 
rect and indirect effects of Valium use as well as 
interactive or moderator effects. As an example of a 
direct effect, one might hypothesize that Valium use 
would directly influence perceived quality of life by 
making the person feel good about life. As an exam- 
ple of an indirect effect, one might hypothesize that 
the effect of Valium use on quality of life might occur 
via the anxiety-reducing properties of the medication. 
As an example of a moderator effect, one might 
hypothesize that use of Valium reduces the effects of 
stresses on anxiety by making the user less concerned 
with the stresses. As another example of a moderator 
hypothesis, one might argue that Valium use effects 
performance or well-being only if the person takes the 
medication daily, for stress-related reasons (rather 
than for musculoskeletal problems), or has a high 
level of anxiety (e.g. [l5]). 
The hypotheses were examined in a two-tailed 
framework. For example, use of a minor tranquilizer 
might increase people’s sense of control over their 
personal and work lives and over their emotions. It 
*The study did not examine ergonomic aspects of per- 
formance nor basic elements of cognitive performance 
such as long- and short-term memory. Summaries of 
that research can be found elsewhere [ 12. 131. Nor did 
the study examine personality characteristics, such as 
trait-anxiety, to see if personality conditioned the hypo- 
thesized social effects of Valium. Such analyses were 
beyond the scope of this study. given an already lengthy 
interview schedule. 
iMore complete detail is available from the Institute for 
Social Research, Publications Division [ 171. 
could also be argued. however. that Valium use might 
decrease this sense of control by making people tee1 
dependent on their medication (e.g. [31]). To take 
another example, one could hypothesize that use of 
a minor tranquilizer could make people more agree- 
able and therefore increase the amount of social 
support which they received from others [16]. Con- 
versely, tranquilizer use might reduce people’s social 
responsiveness in interactions. making it less re- 
warding for others to be socially supportive. and 
thereby reduce rather than increase social support. 
This study examined a large number of such hy- 
potheses including the above examples. A large num- 
ber of analyses were generated to test all the derived 
predictions. The text necessarily focuses on the main 
points of the methodology that was used and of the 
results that were producedt. 
METHOD 
Overaiew 
In a panel survey design. 675 people. 17 years or 
older were interviewed four times, once every 6 
weeks, covering a 6-month period, Of these persons. 
367 reported using Valium at some time during the 
course of the study; the remaining 308 did not report 
using any tranquilizer during the course of the study. 
Characteristics of the respondents are presented be- 
low. 
Respondent selection 
The Michigan Board of Pharmacy, under state law. 
reviewed the study protocol and authorized the in- 
vestigators to obtain the names, addresses and tele- 
phone numbers of clients of pharmacies that agreed 
to participate in the study. The set of respondents was 
intended to include various demographic groups (to 
permit subgroup analyses) rather than to be represen- 
tative of the population. Consequently the pharma- 
cies were drawn from the greater Detroit met- 
ropolitan area in a random sample stratified to 
represent a broad range of neighborhoods with re- 
gard to sociodemographic characteristics. Males, fe- 
males and members of different age groups were 
quota-sampled from the pharmacy records so as to 
have sufficient numbers for analyses within each 
subgroup. 
Previous research had found that users of anxio- 
lytics report more illnesses of all types compared to 
nonusers [6]. For this reason, it seemed best to draw 
nonusers as well as users of Valium from recent 
pharmacy records in order to reduce initial 
differences in health between the two groups (com- 
pared to what it might have been if nonusers had 
been sampled from the community). To this end. 
pharmacy clients were sampled if they had filled a 
prescription within the prior 6 weeks, either for 
Valium or for a nonpsychotropic drug. The 6-week 
period was required to obtain a sufficient number of 
Valium users in the sampled region. Persons were 
excluded from the nonuser (nonpsychotropic) group 
if they had received a prescription for other anti- 
anxiety agents, antidepresents, antipsychotics or. be- 
cause of their CNS-depressant effects, antihistamines. 
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Through this procedure, we drew 2070 names of sults merit attention because this is the first study of 
persons 17 or older*. In addition. we drew a small its kind. and the findings and their interpretations 
number of names from other sources (e.g. business may provide important guidance for future efforts. 
mailing lists) so the interviewers would not know The Results section provides descriptive data on the 
from which source a prospective respondent was similarity of these respondents to the U.S. popu- 
obtained. lation. 
It was possible to contact 1626 people. Of these, 
784 (48’:“) agreed to make a 6-month commitment to 
participate on all four waves of the study and were 
interviewed at Wave 1 t. At the second, third and 
fourth waves of the study, 91-98% of those inter- 
viewed at the preceding wave were reinterviewed 
successfully. Most analyses are based on the 675 
persons who completed all four waves of interviews. 
Comparisons on the basis of numerous social- 
psychological and drug-related variables indicated no 
important differences at Wave 1 between the total set 
of 784 persons interviewed at Wave 1 and these 675 
respondents. 
Each respondent, hereafter referred to as a ‘focal 
respondent’, was asked to nominate a significant 
other person from personal life (e.g. a spouse or close 
friend or relative) and. if employed at least 15 hours 
a week. also to nominate a significant other from 
work life. Approximately 9Oq,, of the focal re- 
spondents provided a ‘personal other’ at each wave 
and 70”,,: provided a ‘work other’. The same personal 
and work others were used at all waves whenever 
possible. 
Datu collection 
Analytic methods ,for addressing response rutc bias 
The response rate may have been influenced by the 
fact that the respondents came from a population of 
persons who were highly anxious or had health 
problems. Such persons, compared to people in the 
general population, may have been less likely to 
volunteer because the 6-month study represented an 
additional demand in their lives (participants were 
accepted only if they agreed to be interviewed four 
times):. 
Given the response rate, replications are required 
to determine generalizability. Nevertheless, the re- 
*We considered a variety of other methods for obtaining 
respondents and rejected them all as too costly or 
infeasible. For example, if we had attempted to select 
users randomly from the population, the low point 
prevalence of use (estimated as only 29, on any one day 
and 12”, annually) would have required the screening 
of thousands of persons to produce the required number 
of respondents for the study [ 181. Pretesting indicated 
that recruitment at pharmacies was also unacceptable 
because it produced a highly selected group of re- 
spondents (usually persons from lower socioeconomic 
groups). 
Participation was voluntary and by informed con- 
sent. Respondents were contacted at their homes. 
after receiving an introductory letter, and usually 
were interviewed there for about 90 minutes at each 
wave. Focal respondents were paid $5 for each of the 
first three interviews and $10 for the final interview. 
Personal others and work others were usually inter- 
viewed by telephone and were not paid. All par- 
ticipants were told that the study dealt with stress and 
well-being in personal and work life. The personal 
and work others were never told anything about their 
focal respondents except that their focal respondents 
had nominated them as potential participants in the 
survey. 
All respondents were interviewed by professional 
interviewers from the Survey Research Center of the 
Institute for Social Research who were trained for 
this study. The interviewers used structured question- 
naires and a standardized interview protocol. 
Measurement 
tNoncontacts included 305 persons who could not be 
located because of inaccurate addresses or who had 
moved and 62 persons who were on vacation. Seventy- 
seven persons were excluded because they were either 
foreign speaking. too ill. or too senile. It was not 
possible to compare the original 2070 persons with the 
final set of respondents on age or gender. 
Multi-item indices of social and psychological vari- 
ables were used to increase the reliability of mea- 
surements. These indices generally had coefficients of 
internal reliability (alpha) in the 0.70s and 0.80s. The 
reliabilities of the measures replicated in a variety of 
subgroups (e.g. males, females, Valium users and 
nonusers, high and low education) and across all four 
waves. 
$We were unable to compare the response rates for this 
study with those from recent nationwide random sample 
surveys of users and nonusers of Valium because such 
information was noncomparable or not reported. Mei- 
linger and Balter [ 191 reported a response rate of 799,, 
for a national random sample of users and nonusers of 
minor tranquilizers. This figure is for persons reporting 
an> use in the past year. It is not possible to distinguish 
in those data between current users. as defined in this 
study. and past users of an anxiolytic medication. a 
category which must describe the large majority of 
respondents in such a study [lg. 61. Nor is it possible in 
those data to distinguish between respondents currently 
being treated for an illness. which was likely to charac- 
terize nonusers in this study. and respondents not being 
treated. 
Unless noted otherwise, all interview questions 
referred to conditions during ‘the last 7 days’. Anx- 
iety, depression and somatic complaints were mea- 
sured using relevant items from the Hopkins Symp- 
tom Checklist [20]. The Hopkins Checklist was used 
to assess changes in relative levels of anxiety symp- 
tomatology rather than to render a specific categori- 
cal diagnosis of anxiety. 
Measures of quality of life [21] and of stress [I I] 
were drawn from standard measures in the literature. 
Other measures of coping, control, performance and 
social support were developed and pretested for 
reliability prior to use in the study [22,23]. The 
Appendix provides some examples of these measures, 
and the complete content of the indices is available 
elsewhere [ 171. 
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It was possible to examine the consensus between 
two observers because both the significant other and 
focal respondent reported on the focal respondent’s 
performance, quality of life, social support, and 
social conflict. Data from Wave 1, which are typical, 
showed that there was good consensus in some 
domains and not in others. For example, the focal 
respondent’s ratings of overall quality of life and of 
worklife were moderately to strongly correlated with 
ratings by the personal and work others (0.61 and 
0.44 respectively). The focal respondent’s ratings of 
technical and social performance in personal life 
correlated 0.18 and 0.25 with the respective ratings 
made by the personal life significant other. In the 
work life domain, the respective correlations were 
0.09 and 0.30. 
Given the generally good internal reliabilities for 
the measures from the focal respondent and the 
significant others, the low correlations between the 
two sets of respondents suggests that each type of 
person represents a different perspective. Each per- 
spective perhaps is the product of particular bias and 
access to different information. 
A detailed history of drug use in the prior 6-weeks 
was obtained, as was some information regarding use 
in the prior year. Particular detail was pursued with 
regard to consumption of frequently used medica- 
tions which have either CNS-stimulant or -depressant 
effects. Seventy-five percent of the data regarding 
prescribed dosages of medications was recorded from 
medicine bottle labels; the remainder was based on 
respondents’ memories. Distinctions were made in 
the coding and analyses of these data between ‘use as 
needed’ (PRN) prescriptions and fixed schedules. 
In addition, respondents were asked for retro- 
spections about use of Valium, anxiety, and quality 
of life for each of the 6 weeks preceding each 
interview. At Waves 2-4 they were also asked for 
retrospections regarding the seventh prior week, 
which was the week of the preceding interview; this 
allowed checks on the accuracy of retrospection. 
These weekly data on Valium-taking, anxiety, and 
life quality were obtained on a form that resembled 
a calendar; they are referred to below as ‘calendar 
measures’. 
These retrospective calendar measures were found 
to be reasonably accurate. Restrospections at Waves 
2, 3 or 4 correlated on the average with matched data 
collected at the previous wave in the range from 0.5 
for anxiety to 0.8 for Valium-taking. Recall may have 
been good for two reasons: (a) the phenomena may 
be relatively stable and (b) we worked at improving 
recall by first asking respondents to recall an event 
that stood out in their lives for each week. 
Churucteristics of‘ respondents 
As noted. the intent was not to draw a random 
sample of the population. Nevertheless, comparisons 
with the 1979 U.S. Census Data [24] indicated that 
the respondents were similar to the U.S. population 
with respect to the distributions on sex, age and 
education. The mean age for the respondents was 46. 
Average education was I2 years. Average family 
income was in the range of $15,000 to $24,999 per 
year. Fifty-four percent of the respondents took 
Valium at some time during the study. 
To provide sufficient numbers of both sexes among 
the Valium users. the proportions of male and female 
users in this study (39 and 61”,,. respectively. at Time 
1) were more equal than those found in national 
sample surveys [6. 191. Among nonusers. 46”,, were 
male, 54”, were female. The higher proportion of 
Blacks (2l”J than found nationally (lo”,, [24]) reflects 
the demography of the Detroit metropolitan area. 
Valium users tended to be slightly older. less 
educated and have less income compared to non- 
users. Valium users also reported lower subjective 
quality of health, higher anxiety, higher depression. 
and lower subjective quality of life. Such differences 
reflect the association between distress and use of 
anxiolytic drugs found in random sample surveys of 
the U.S. population [5. 61. 
Comparisons with nationwide prescription surveys 
[25] showed that, as in the country as a whole. 
respondents in this study were prescribed Valium 
most often by physicians in general practice or in 
internal medicine; osteopaths and psychiatrists were 
the next most likely to prescribe this medication. 
With regard to physical health, users of Valium in this 
study were similar to those in a recent national 
random sample [6]. Users were four times as likely to 
report some health problem as nonusers in this study 
even though the nonusers were pharmacy clients too. 
Users in this study, like those found in the national 
sample, were more likely to report chronic illnesses 
such as high blood pressure and arthritis whereas 
nonusers were more likely to report acute medical 
problems. 
The major potential difference between re- 
spondents on this study and in national random- 
sample cross-sectional surveys [5,6] is the percentage 
of persons in this study who reported taking Valium 
daily or nearly every day. At Wave I, 48”, of those 
taking Valium reported such use (the percentages at 
Waves 24 were similar). Mellinger and colleagues 
reported that 211; of those who took Valium daily 
took it for as long as 4-84 months [6]. These two 
studies’ methods of measurement of Valium use are 
not directly comparable. Consequently, the data only 
suggest that daily users were overrepresented in this 
study. Measures of use incorporated in our study 
need to be used in a random sample survey to 
determine the generalizability of the descriptive sta- 
tistics regarding patterns and levels of use reported 
here. To deal with the possible overrepresentation in 
daily usage patterns. analyses examined the social 
effects of daily Valium use separately from those of 
other patterns of use. Within-group analyses were 
also performed separately for males and females, 
blacks and whites, high and low dosage users, and 
many other subgroups to determine if the results 
might differ from one group to the other. Where 
appropriate, comparisons of results were made before 
and after controlling statistically for stress-related 
variables such as health patterns. negative life events 
[IO] and social conflict. 
RESULTS 
Ooeroiew t3f Vulium use 
Anxiety, tension, keeping calm or keeping relaxed 
were mentioned by 70’!,, of the respondents as reasons 
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for taking Valium; insomnia was mentioned by 17’::;; 
and the only commonly mentioned physical reason 
was a pulled back or sore muscles (9’:/,). Note that 
these were respondent reports rather than diagnoses 
from medical records. 
The most commonly prescribed doses of Valium 
ranged from IO to 20 mg per day. Fewer than 91, of 
prescriptions were for 30 mg or more per day. 
Patients prescribed specific regimens (i.e. not PRN) 
tended to take less rather than more milligrams than 
prescribed, replicating prior research on compliance 
with anxiolytic treatment [26]. The most commonly 
reported actual usages ranged between 2 and I5 mg 
per day (8892) a range within guidelines described by 
the Valium package insert [27]. Only two persons 
reported taking more than 40 mg per day at Wave 1. 
The large majority (83%) of persons taking Valium 
within the 6 weeks preceding each interview also 
reported taking the medication within the seven days 
prior to each interview. The majority of Valium users 
(59%) took some Valium during all four of the 
6-week periods prior to each interview. Nevertheless, 
there were considerable ranges of doses and patterns 
of use across and within the 6-week periods between 
interviews. During the 6 weeks preceding the Time 1 
interview, 33% of the users of Valium reported taking 
the medication ‘only once in a while’, almost half 
(47%) reported taking it ‘every day or every other day 
the whole time’ and the remainder took it either 
‘some weeks almost every day, other weeks not at all’ 
(1 I”,/,) or at more evenly spaced intervals which were 
less frequent (‘at least once a week the whole time’; 
9”/,). The distributions of pattern of use at Times 2-4 
were similar to that at Time 1. 
The number of drinks of alcohol consumed by 
Valium users compared to nonusers was about the 
same (e.g. at Wave 1, the respective means were 5.7 
and 6.1 drinks per week; the respective standard 
deviations were 14.2 and 11.9). (Although compar- 
able national sample data are not available, a 1979 
survey [37] showed that 33’6 of the population were 
nondrinkers, and among the drinkers, ‘heavier’ 
drinkers were classified as consuming more than 40 
drinks per week. The averages in this study fall well 
below that level.) Persons who took Valium daily 
were less likely to consume alcohol than nonusers 
(e.g. 48y0 compared to 669,; of the nonusers at Wave 
1. P < 0.01). but among those who drank any alcohol 
at all during this period. there was no difference in the 
amount of alcohol consumed. The design of the study 
does not allow one to determine the extent to which 
the differences in the percentage of drinkers among 
daily Valium users and nonusers was due to self- 
selection. substitution of Valium with alcohol (and 
vice-versa) or compliance with physician recommen- 
dations regarding the use of alcohol and Valium 
simultaneously. Valium users also tended to smoke 
more cigarettes than nonusers. but Valium users and 
nonusers did not differ with regard to use of caffeine 
or street drugs. Street drug use was very low among 
all respondents. and there was no evidence that 
Valium use led to use of street drugs. Valium users 
tended to take more prescribed nonpsychotropic 
drugs than did nonusers. 
Valium users reported that their prescribing physi- 
cians were generally supportive. a finding counter to 
the criticism that tranquilizer prescribing indicates 
some physicians’ relative inattention to the psycho- 
social needs of patients (281. Lastly. Valium users 
reported that the medication helped them control 
their lives, although there was no statistical relation 
between the amount of Valium taken and users’ 
scores on various measures of control. 
Sociul c$hcts of Vulium use: primury unulyses 
Results of bivariate analyses are described first. 
They are followed by results of multivariate analyses 
that introduce various statistical and subgroup con- 
trols. 
Correlutionul, lugged unulyses. Using the weekly 
retrospective calendar data, it was possible to exam- 
ine how ratings of quality of life and .anxiety cor- 
related with Valium use when Valium use and these 
other variables were measured simultaneously, and 
when Valium use was measured before (i.e. l-24 
weeks before) and after (i.e. l-24 weeks after) quality 
of life and anxiety. The measure of Valium use 
employed in these and most other analyses reflected 
the total number of milligrams taken each week. 
Figure l(a) and (b) summarize the results separately 
for the total set of respondents (users plus nonusers) 
and for persons who took some Valium during the 
6-week period preceding each interview. None of the 
relations was very strong. Regardless of the lag, 
anxiety was always positively (although weakly) cor- 
related with use of Valium, the average zero lag 
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Fig. 1. (a) Relation between Valium-taking and anxiety at 
various lags. (b) Relation between Valium-taking and qual- 
ity of life at various lags. 
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correlation being about 0.14. Conversely, the average 
zero-lag correlation was about -0.12 between 
Valium-taking and quality of life. and the correlation 
was always negative regardless of the lag-i.e. poor 
quality of life was associated with the use of Valium. 
For both quality of life and anxiety, the simultaneous 
relation with Valium-taking tended to be slightly 
stronger than most of the lagged relations. The 
correlation between quality of life and anxiety was 
-0.52 at lag 0 and decreased by weeks 4-6 in the 
range -0.1 to -0.2. The relation declined only 
slightly more with lags beyond 6 weeks. These results 
suggest that if causal relations existed, they were 
more likely td occur within the 7-day span of the 
measures rather than across longer intervals. 
Lagged relations were also examined using data 
from the other portions of the interview. referring to 
levels of Valium use, anxiety, quality of life, and other 
social-psychological variables in ‘the last 7 days’ prior 
to each of the four interviews. Analyses examined the 
relations between these variables measured with 
simultaneous, 6-, l2- and I g-week lags. Again, use of 
Valium and anxiety (here measured by the Hopkins 
Symptom Checklist) were always positively cor- 
*Three features allowed this analysis to control statistically 
for imperfections in the measures: (a) two meth- 
odological factors were included that reflect response 
styles or biases in answering the retrospective calendar 
measures. One factor represented the calendar mea- 
surement of quality of life and anxiety; the other 
represented the calendar measurement of Valium use. 
We presumed that the effect of each methodological 
factor on its measures would be equal and hence 
constrained the analyses to reflect this. (b) The model 
included a residual input to each questionnaire measure. 
This residual represents other factors. unrelated to the 
methodological factors and the primary construct. that 
might influence the measure. For example, the residual 
input for Anxiety is 0.23 at Time 2 and 0.19 at Time 
3. (c) For the non-calendar measures, allowance was 
made for the possibility that the residual inputs to any 
particular measure assessed at one wave might covary 
with the residual inputs to that measure assessed at 
another wave. If one falled to take into account such 
covariation in these residuals. one could err III esti- 
mating the between-wave links among the primary 
factors. (Illustration of these covariations has been 
omitted from Fig. 2 to simplify the schematic although 
they were estimated as part of the model.) 
tOnce such a model is specified. the magnitudes of its effects 
are estimated (i.e. the magnitudes of the links among 
constructs. between constructs and measures and among 
measures) so as best to account for the observed 
relations in the data. The closer the estimated mag- 
nitudes of the relations to the observed data (sum- 
marized by the chi-square-per-degrees-of-freedom ratio, 
by the mean absolute residual. and by Hoelter’s CN 
statistic [3 I]), and the more theoretically reasonable the 
estimates (e.g. positive effects where expected. negative 
effects where expected. small or large effects as ex- 
pected), the more adequate the hypothesized model. 
Based on the fit statistics presented with Fig. 2. it is clear 
that this model reproduces the observed relations quite 
well. 
ZAlternative models allowed. for example. for direct elects 
of Valium use on performance,in personal life and on 
quality of life rather than for indirect effects via changes 
in anxiety. 
related regardless of the length and direction of the 
lag. and the relation was strongest for the simul- 
taneous corrections (maximum I’ = 0.30). Similari). 
regardless of the specific la! examined. Valium-taking 
tended to be weakly assoclnted with poor quality of 
life. poor performance in work and personal life. low 
social support. perceived lack of internal control. 
poor perceived health and high levels of stress (max- 
imum Y = 0.28). Over 1000 such relations were exam- 
ined. This general positive association between stress 
and use of minor tranquilizers is like that in national- 
sample cross-sectional survey results obtained by 
other investigators [5. 61. 
The structural modelling described below. provides 
a summary of the main findings from the cross- 
sectional as well as longitudinal analyses. in a com- 
pact manner. 
Change score anui!.ses. Although change scores 
have some psychometric disadvantages. such as re- 
duced reliability [29], they have the advantage of 
canceling out certain systematic response errors from 
each wave. Analyses using change scores did not alter 
the basic pattern of findings described above. In 
general, the relations between changes in Valium use 
and changes in the indicators of stress. performance 
and well-being were weak (Y < 0.2) regardless of 
whether the changes occurred simultaneously or the 
changes in Valium use preceded or followed changes 
in the indicators of social effects. 
Structurul modeling. Traditional methods of hy- 
pothesis testing (such as analysis of variance or 
multiple regression) examine relations among nleu- 
sures of the constructs in the hypotheses. Such ana- 
lytic methods provide imperfect tests to the extent 
that the measures of the variables are not good 
representations of the constructs. In contrast. struc- 
tural modeling (e.g. LISREL IV, see [30]) allows 
one, with certain assumptions, to estimate relations 
among the constructs. These estimates are made 
possible by the use of statistical controls for random 
errors of measurement, for correlated measurement 
errors (e.g. when a predictor and a dependent vari- 
able are correlated because they are measured with 
the same procedure), and for potentially confounding 
variables, including the differences between users and 
nonusers of Valium in initial levels of anxiety. per- 
ceived stress, and perceived physical health. We be- 
lieve the modeling approach provides the best avail- 
able estimates of the effects of Valium use because of 
these controls*. 
Using this approach. the investigator specifies a set 
of hypotheses, referred to as the model, and tests how 
well the data conform to the modell-. The model in 
Fig. 2 was the best of several models in terms of its 
ability to describe the actual relations in the data, the 
theoretical reasonableness of the parameter values, 
and the theoretical reasonableness of the obtained 
structuref. 
For example, health was modeled as increasing 
stress, and both stress and health were modeled as 
increasing anxiety. Anxiety, in turn, was modeled as 
leading to the comsumption of Valium and to decre- 
ments in performance in personal life. And poor 
health, high stress amd’anxiety, and low performance 
were, in turn. modeled as producing a decrease in 
perceived quality of life as a whole. Valium was 
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modeled as having effects on performance and quality 
of life-as-a-whole via the effects of Valium on anxiety. 
And most of the concepts were modeled to allow for 
direct effects on themselves at later times. 
In Fig. 2, the constructs are represented by ovals. 
The measures of the constructs are represented by 
rectangles. The subscipt within each oval or rectangle 
represents the particular wave of data collection. 
Arrows between ovals represent estimates of the 
strength of relations between constructs after control- 
ling for measurement error (e.g. at Wave 2, the 
strength of the relation between health and anxiety is 
-0.44). The arrows from ovals to the rectangles 
represent the effects of each construct on how people 
answer the questions about the construct; hence. they 
reflect the validity of the questions (e.g. anxiety is 
reflected at Wave I in the calendar measure with a 
validity of 0.58 and in the Hopkins measure with a 
validity of 0.79). 
In this particular model. the data at Waves 2-4 
merit the closest attention because they take into 
account prior (i.e. from the previous interview) levels 
of stress, health. Valium use. performance and qual- 
ity of life. The model shows a number of reasonable 
relations within the last three waves. For example, 
and as expected, poor health and stress preceded 
increased anxiety (coefficients ranged from -0.18 to 
-0.44 and from 0.67 to 0.82, respectively). Anxiety 
had negative effects on performance in personal life 
(-0.20 to -0.27) and on quality of life as a whole 
(-0.44 to -0.55). Performance had a positive effect 
on quality of life (0.33-0.39). Health and stress were 
generally unrelated. 
The current levels of anxiety and of life quality in 
this model were attributed mainly to the current levels 
of the other constructs, with little or no direct effects 
from six weeks earlier. Although the model allowed 
for the possibility that Valium-taking would have an 
effect on anxiety 6 weeks later, and, through anxiety, 
on performance and life quality, these links were zero 
or near zero*. 
These results provide one of the more important 
findings of the study-an explanation for the positive 
relation between Valium use and psychic distress 
found in cross-sectional studies [5. 61, as well as in this 
study’s bivariate analyses (see above). Once prior 
levels of anxiety, health and stress were controlled. 
there was no relation between Valium use and anxiety 
either cross-sectionally or over time. 
These controls also led to the near-zero effect of 
anxiety on Valium-taking at Waves 2-4. This finding 
suggests the following interpretations: Whereas a 
high level of anxiety may lead to a prescription for 
Valium (or any other anxiolytic). continued use may 
not be triggered by anxiety under the following 
conditions: when the person (a) uses the medication 
daily because of instructions from the physician or 
*The effect of Valium use on subsequent level of quality of 
life can be computed by multiplying the coefficients 
along each causal path that links Valium use to quality 
of life and summing the products. The same procedures 
can be followed for computing the link between Valium 
use and performance. These products are all very small 
because the Valium-anxiet) link is weak, 
based on habit. including the habit of preventive or 
anticipatory use or (b) uses the medication nondaily 
for the management of anxiety that lasts only for a 
brief period such as a day. With regard to the first 
condition, although almost 5O’J, of the users of 
Valium were daily users at each of the waves, the 
study was not designed to examine preventive or 
anticipatory use. With regard to the second condi- 
tion. the measures of Valium use and of other 
variables were not designed to detect the elfects of 
such highly transitory use, but, rather, were designed 
to summarize time periods of at least 7 days. Further 
research will be required to evaluate the validities of 
these potential interpretations. 
Social t$kcts of Valium use: supporting ana!)ws 
Subgroup analyses. Although there was no evidence 
of either harmful or beneficial social effects of Valium 
use when all study participants were analyzed to- 
gether, it was possible that some social effects might 
appear for specific subgroups of respondents. Sub- 
groups were formed in a number of ways: by whether 
Valium had been taken for anxiety or for other 
-reasons, the amount of social support the person 
reported receiving from the Valium-prescribing phy- 
sician and others, gender, daily use versus other 
patterns of Valium use, use of other medications. 
perceived internal control, attitudes towards tranquil- 
izers, demographic variables, use of coping tech- 
niques, health, and other stressors of life. Over 6000 
analyses examining various lags were performed 
across the several waves of data. No evidence was 
found for subgroup effects beyond those due to 
chance. 
Another search examined the extent to which 
Valium use either buffered (reduced) or exacerbated 
(increased) the relations between stresses and quality 
of life or other outcomes, such as anxiety, depression. 
performance and perceived control. Although there 
was a slight tendency for Valium use to buffer such 
relations, the magnitude of the effect was generally 
weak, did not replicate well across waves. and was 
offset by some instances in which Valium use seemed 
to exacerbate effects of stress on other outcomes. 
Analysis of covariance. This set of analyses, like the 
structural modeling analyses, controlled for the 
higher levels of perceived stress and poorer health 
among users of Valium. Some of these analyses 
selected small subsets of both users and nonusers of 
Valium who had high initial levels of anxiety on the 
Hopkins Checklist-levels typical of those found at 
the start of treatment in clinical trials. Three separate 
sets of analyses were performed: (1) for dai/y users 
(highly anxious persons who reported taking Valium 
daily or nearly daily during the 6 weeks prior to Wave 
1 through Wave 2-a period of about 12 weeks), (2) 
for new users (persons who reported taking Valium 
for the first time during the 6-week period prior to 
Wave 1) and (3) for highly anxious nonusers. With 
these restrictions, the number of new users was only 
19, and the number of cases for the other two groups 
was about 50 (the sample size varied depending on 
the variables analyzed). 
These analyses examined the effects of Valium use 
on performance, anxiety, depression, the well-being 
of the personal other, and many other variables. No 
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notable evidence of any differences was found among 
the three groups. Overall there was no evidence of 
any long-term social effects. 
Wirhin-person unulyses. Whereas the preceding 
analyses all examined the social effects of Valium use 
between persons but within and across waves of the 
study, the next two types of analyses examined these 
relations person-by-person (within persons, across 
time). The first type of analysis used the retrospective. 
24 weeks of calendar data to examine, person-by- 
person, weekly changes in anxiety and quality of life 
before and after use of Valium. Anxiety tended to 
decrease and quality of life to increase after Valium 
use. Similar changes were observed, however, when 
the same individials experienced an increase in anx- 
iety but did not use Valium. Nonusers showed a 
similar pattern of increase and subsequent decrease in 
anxiety. With similar results. these analyses were 
repeated separately for new users, for intermittent 
users (persons who started taking Valium after a 
period of at least 6 weeks of not taking the medica- 
tion) and for several other groups of users. The 
findings provided no clear evidence that Valium use 
uniquely influenced either anxiety or quality of life 
over a period of at least a week. 
There was a possibility that some persons might 
show positive, others negative, and others no cor- 
relation between Valium use and anxiety or quality of 
life. Such variation might be due to differential 
responsiveness to Valium. This possibility was ex- 
plored in the second type of analysis by using the 24 
weekly points of the calendar data to compute sepa- 
rate correlations for each individual to determine 
how Valium-taking varied with anxiety or quality of 
life across time but within persons. For each person, 
correlations were computed separately for relations 
based on simultaneous measures as well as lags of I, 
3. 6 and 9 weeks (the lags included those where 
Valium use preceded as well as followed the anxiety 
and quality of life ratings). These correlations were 
then related to 82 other variables, including stress, 
social support. coping. control. performance, use of 
medications and other substances, quality of life, and 
demographic variables. Significant notable nega- 
tive or positive within-person correlations between 
Valium use and either quality of life or anxiety 
occurred with such infrequency as to represent only 
chance. 
Other findings deuling with sociul &c.ts 
Elsewhere it has been suggested that the use of 
minor tranquilizers may dull the user’s sense of the 
external environment and its stresses and may numb 
normal emotional reactions so that users are not able 
to report their feelings to others [32]. The data from 
this study do not support these conjectures. The 
statistical relations between stress and emotion for 
users and nonusers were generally the same across 
most waves. Furthermore, changes in stress and in 
emotion over the four waves of the study among the 
nonusers were paralleled by similar changes for the 
users of Valium (stress declined in personal life and 
in work life. and emotional states improved for both 
groups with no statistical differences between the 
groups after controlling for initial levels). Among 
users of Valium. the higher levels of stress. including 
poor health, were accompanied by higher levels of 
negative affect-a normal emotional response in the 
sense that nonusers of Valium also showed similar 
response sensitivities. 
DISCUSSION 
Overall, this study found little evidence that use of 
the minor tranquilizer Valium had any social effects, 
either harmful or beneficial. Although there were 
small, positive cross-sectional relations between indi- 
cators of distress and use of Valium, these relations 
were near zero over time when statistical controls 
were introduced for prior conditions of stress and 
health. A lesson of these analyses is that it is im- 
portant to consider the stabilities and the antecedent 
effects of variables which are likely to influence 
the use of anxiolytics and potential outcomes of 
anxiolytic use such as anxiety and quality of life. 
It was conceivable that the findings might have 
been an artifact of a particular statistical method of 
analysis. For this reason, multiple techniques were 
used for examining the data across as well as within 
persons. Each analytic method allowed us to take a 
different perspective on the data. The results were 
similar across all of the methods. 
With regard to other social issues, users of Valium 
perceived their prescribing physicians as socially sup- 
portive rather than unsupportive. There was no evi- 
dence that Valium use numbed emotional re- 
sponsiveness: the relations between social stresses 
(e.g. role conflict at work) and emotions (e.g. anger) 
were the same for users and nonusers of anxiolytics. 
Although the study was not designed to examine 
drug abuse, it was evident that there was little use of 
street drugs among these respondents as a whole, no 
difference between users and nonusers of Valium with 
regard to the use of such drugs, and a tendency for 
users of Valium to take less rather than more than the 
amount of Valium prescribed. This tendency toward 
undermedication with minor tranquilizers has also 
been noted in clinical trials [33]. 
Interpreting the longitudinal.findings 
This study was designed chiefly to examine social 
effects of the use of Valium. The fact that no major 
social effects were detected requires explanation. 
It was hypothesized that.social effects might occur 
either directly or indirectly as the result of Valium 
use. If brought about indirectly, such effects might 
have been the secondary result of a reduction in 
anxiety, which is typically found in clinical trials [I]. 
Thus, this study’s finding of no major social effects 
might be explained by its corresponding finding of no 
lasting effects of Valium use on anxiety. Con- 
sequently, it is worth examining why the study 
detected no anxiolytic effects of Valium use. 
One possible reason why Valium use was not found 
to reduce anxiety is that the Valium users in the study 
may not have taken sufficient doses of the medica- 
tion. However, although users of Valium did tend to 
take less Valium than prescribed, the amounts they 
took are considered adequate to produce anxiolytic 
effects and fall within the recommended doses de- 
scribed in the package insert. Nevertheless, we con- 
ducted separate analyses for persons who took 
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different doses or had different patterns of use (e.g. 
daily vs intermittent) and the findings remained basic- 
ally unchanged. Thus, low dose does not provide an 
explanation. What other factors might account for 
the lack of any detectable anxiolytic or social effects? 
As noted at the outset, this study was designed to 
search for long-term rather than transitory (e.g. those 
that might occur only for a day or so after taking the 
medication) anxiolytic and social effects. The ratio- 
nale was that most of the social issues raised regard- 
ing the use of tranquilizers dealt with long-term 
changes. If people took Valium to manage very brief 
episodes of anxiety (much like taking an aspirin for 
a headache), both the anxiolytic and social effects 
might be short-lived. Consequently, it is possible that, 
any anxiolytic effects might have been too short-lived 
to detect in this study. This is plausible because the 
strongest associations among use of Valium, anxiety, 
and quality of life occurred at lag zero and tended to 
decrease as the lags increased to one or more weeks. 
(Although clinical trials suggest that Valium’s anx- 
iolytic effects occur in as little as one week [15], most 
trials focus on interventions of l-6 weeks rather than 
period’s shorter than that. The package insert [27] 
does not indicate a specific minimum period of recom- 
mended anxiolytic use.) 
The other side of this concern might be that if there 
were any social effects of Valium use, they might take 
longer to develop than the 6-month time span of this 
study. However, the lagged data described above 
indicated no such trend. Indeed, the magnitude of 
effects examined in this study decreased, rather than 
increased, with the passage of time. 
It is also possible that, if there were any social or 
anxiolytic effects, they might have occurred prior to 
when people entered the study. Only prior mea- 
surement could have resolved this issue. However, 
new users of Valium and users who started and 
stopped taking Valium during the course of the study 
provided one opportunity to look at anxiety and 
social effects over a relatively short period of new or 
renewed use. Analyses of the small number of new 
users and of intermittent users did not alter the basic 
findings*. 
No association between use of Valium and either 
anxiety or social effects would be likely to occur, even 
over the short run, if people took the medication 
prophylactically. If people took Valium in antici- 
pation of events that they perceived as potentially 
anxiety-provoking. then one might expect anxiety to 
be low both before and after taking Valium: other 
social effect outcomes also might be relatively un- 
changed. This study lacks the data required to evalu- 
ate this explanation. and we are not aware of any 
other study which assessed the incidence and preva- 
lence of prophylactic use. 
*Another possible cxplanat~on ol’the results is that Valium 
use was effective in improvlng quality of lice. but no 
more so than anything else. This interpretation derives 
from case-by-case analyses of the data. Those analyses 
showed that. slier an increase in anxiety. anxiety 
generally decreased and quality 0T life generally in- 
creased. but no mow so when Valium was taken than 
when it was not. Only a placebo irkI can determine the 
validity ol’ such an explana~wn. 
Similarly, no association between Valium use and 
anxiety or social effects would be detected if people 
were using alcohol and Valium in a complementary 
fashion to manage anxiety continuously. However. 
when those taking alcohol (or other CNS stimulant 
or depressant drugs) were examined separately from 
those who were not taking such drugs. the overall 
results were unchanged. 
A lack of association might also occur if users of 
Valium had levels of anxiety and depression that were 
not clinically responsive to the effects of a minor 
tranquilizer [34.35]. However, analyses of subgroups 
with different initial levels of anxiety and with 
different initial combinations of anxiety and depres- 
sion did not alter the basic findings. 
There is the possibility that social and anxiolytic 
effects were not detected because the measures were 
unreliable or invalid. This is refuted by the rigorous 
criteria that were used in developing the measures. 
Internal reliability was demonstrated in a variety of 
key subgroups including users and nonusers of 
Valium. Validity of the measures was demonstrated 
by bivariate and multivariate analyses which showed 
that measures of the stresses, social support. per- 
formance, subjective health, anxiety, and quality of 
life were related to one another in marked, statisti- 
cally significant and theoretically meaningful ways 
[36]. Furthermore. the simple, cross-sectional cor- 
relations between use of Valium and measures of 
distress were similar to those found in national 
random-sample surveys of the United States [5. 61. 
Finally, the lack of association between Valium use 
and the various measures of well-being might be valid 
only for the respondents in this study; the effects 
might be different for the larger population of Valium 
users. Although the results should be replicated on a 
random sample of users and nonusers of Valium (or 
of other minor tranquilizers), we find no specific 
reason for predicting that the resulting relations 
reported here would be different. 
Links to clinical trials and implications for future 
research 
For most competing explanations, we conducted 
subgroup analyses or made use of other statistical 
techniques to control for potential artifacts. In each 
case the basic findings of the study were unchanged- 
Valium use did not appear to have any effects on 
anxiety or on many other social psychological vari- 
ables when the minimum time frame for measuring 
use of the medication and level of the effects was 
seven days and when the maximum interval was 6 
months. In view of the numerous clinical trials 
demonstrating the anxiolytic effects of Valium and 
similar benzodiazepines, the most probable conclu- 
sion is that Valium has no long-term social effects, 
either harmful of beneficial. within the time frames 
and range of social elects examined in this study. 
Rigorous clinical trials are designed to rule out the 
many artifactual and competing explanations that we 
have just addressed. On the other hand. such trials 
introduce conditions which are antithetical to a study 
of actual. nonexperimental use. Hence we suggest 
that clinical trials might be used in the post-market 
surveillance period to confirm findings which have 
been identified through field surveys. In this way, 






















clinical trials. with their increased precision, and field 
surveys, with their advantages of breath and econ- 
omy in examining large numbers of patients in natu- 
ral settings, could be combined to generate a basic 
and complementary set of findings regarding the issue 
of the social effects of anxiolytic drug use. 
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but not identical to, indices developed by other in- 
vestigators. Those details as well as the full content of the 
measures are available elsewhere (171. Also available are the 
details of the calendar measures of Valium use, quality of 
life, and anxiety which were used to obtain retrospective 
data and the details of the protocol for assessing medication 
use. These procedures are too complex to present here and 
require special materials. 
Potential indicarors of srrain 
Anger (I in the 0.80s). In the last 7 days, how much have 
you felt.. (1) furiously angry, (2) mad at someone, (3) so 
angry that you felt like hitting someone? Response scale: 
I = not at all. 2 = a little bit. 3 = quite a. bit and 
4 = extremely. 
illcohol consumption. (I) I would like to ask you about 
alcoholic beverages-i.e. wine. beer and liquor. Again, think 
back over the last 7doys. On how many of those days did 
you drink any alcoholic beverages? (2) In rhe last 7duys. on 
the days that you drank alcoholic beverages, how many 
drinks did you usually have? By drink I mean shot or glass. 
(3) (Asked of persons who reported no drinks in the last 7 
days) In the last monrh...(text continued as in items I and 
2 above). 
Qualify, o/‘li/i?: heulrh (a in the 0.80s and 0.90s). (I) How 
would you rate your health at present?--excellent, good, 
fair. or poor? Response scale: (implicit in item). 
(2) In the last 7 days, how much has your physical health 
kept you from doing the things you want to do? Would you 
say it interfered nor at a//. J’USI a liltle, some, or a great deal? 
Response stole: (implicit in item). 
Qualit?: ~~fl+: t>arious sub-indices (r generally in the 0.80s 
und 0.90~). (1) How do you feel about the way you handle 
problems that come up in your life? (2) How do you feel 
about your physical appearance, the way you look to 
others? (3).. .what you are accomplishing in your life? 
Response .sca/e: I = terrible, 2 = unhappy, 3 = mostly 
dissatisfied, 4 = mixed (about equally satisfied and 
dissatisfied). 5 = mostly satisfied. 6 = pleased and 
7 = delighted. 
Sociul conflicr. sociul support. control and s:resses 
Sociul cotzflict (z gene&/y in the 0.70s-0.90s). In the last 
7 days. how much did some one person.. ( I ) misundersrand 
the way you think and feel about things? (2) .get on your 
nerves, (3) show that he or she disliked you? Response 
.scule: I = not at all. 2 = just a little. 3 = some. 4 = quite a 
bit, and 5 = a great deal. 
Sociul .rupporl (IX gmeruliy in rhe 0.70~ and 0.80~ ). In the 
last 7 days. how much did some one person...(l)...be a 
source of encouragement and reassurance? (2). treat you 
with respect? (3). .show that he or she cured about you as 
a person’? Re.sponw SUI/~: (same as social conflict items). 
Socicrl supporl from physiciun (a generully in the 0.60~ und 
0.70~). (I) When you visit your (KIND OF DOCTOR), how 
much time is there to discuss with him or her UN the things 
you want to talk about? Response scule: (same as social 
conflict items except I = none or very little). 
(2) Would you say your (KIND OF DOCTOR) is very 
cold towards people. somewhat cold towards people. neither 
cold nor warm. somewhat warm, or very warm towards 
people’! Rc.\pomc WI/~: (implicit in item). 
Conrrol(r generally in the 0.60s and 0.70s). (1) In the last 
7 days. how much of what has happened in your personal 
life depended on what I’OU said and did? (2) .depended on 
what others said and did? (Note: items assessed control by 
self, by others. and by chance or luck. over the domains of 
personal life and of emotions. Response scale: (same as 
social conflict items). 
Stress: Role ambigurr.v (z in rhe 0.70s and 0.80s). In the last 
7 days, how sure or unsure were you about,. _(I), whether 
the people in your personal life would approve of the way 
you were doing things? (2). what others expected of you’? 
Response scale: I = very sure. 2 = fairly sure. 3 = neither 
sure nor unsure. 4 = fairly unsure. and 5 = very unsure. 
Performance (x general11 in rhe 0.60s-0.80s) 
In the last 7 days, how irei/ were you doing 
at .(I). handling the responsibilities and daily demands 
of your personal life? (2). getting along with others in your 
personal life? (3). making the right decisions? Response 
scale: I = very poorly, 2 = not very well. 3 = all right. 
4 = very well and 5 = exceptionally well. 
Perceived helpfulness of Valium and perceived influence on 
control (z in the 0.70s and 0.80s) 
(1) Think about how (MEDICATION) affects your con- 
trol over your emotions. Does it increase your control. 
decrease it, or not really affect it at all? IF THE PERSON 
REPLIED ‘INCREASE’. Does it increase your control a lot 
or only a little? IF THE PERSON REPLIED ‘DE- 
CREASE’. Does it decrease it a lot or only a little? 
(2) Think about how it affects your ability to deal with the 
problems in your life. Does it increase your ability to deal 
with them decrease it. or not really affect it at all? (Follow- 
up questions were like those in the preceding item). 
(3) How helpful do you find (MEDICATION)? Response 
scale: I = not at all. 2 = just a little, 3 = somewhat, 4 = very. 
5 = extremely. 
Attitudes toward tranquilizer use (2 in [he 0.70s and 0.80s) 
(I) Based on what you know about tranquilizers, do you 
generally approve or generally disapprove of the present use 
of them, or are you undecided? Response scale: (implicit in 
item). 
(2) I’m going to read you some statements about tranquil- 
izers. After I read each one, I want you to tell me how much 
you agree or disagree with the statement. (a) Using tranquil- 
izers just prevents people from working out their problems 
for themselves. (b) It is better to use will power to solve 
problems than it is to use tranquilizers. Response scale: 
l = strongly disagree, 2 = disagree. 3 = neither agree nor 
disagree, 4 = agree and 5 = strongly agree. 
Meusures ofrhe significant others (a generally in the 0.70s and 
0.80s) 
Measures obtained from the signilicant other in personal 
life and at work were generally similar to those described 
above. For example. significant others in personal life 
completed self-administered measures of the Hopkins 
Symptom Checklist and provided performance ratings with 
wordings identical to those illustrated above for the focal 
respondent. 
